Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

KA Inhibitors

Santa Cruz Biotechnology now offers a broad range of KA Inhibitors for use in various applications. KA inhibitors, or kainate receptor antagonists, are an essential category of chemicals in neuroscience research. These inhibitors specifically target kainate receptors, a subtype of glutamate receptors involved in excitatory neurotransmission within the central nervous system. By modulating the activity of kainate receptors, KA inhibitors allow scientists to study the role of these receptors in synaptic plasticity, neuronal development, and neural circuit function. Their selective binding properties make them invaluable tools for dissecting the complex signaling pathways mediated by glutamate, the primary excitatory neurotransmitter in the brain. Furthermore, KA inhibitors are used in experimental models to investigate the mechanisms underlying neurodegenerative diseases, as they can mimic or block the pathological overactivation of kainate receptors observed in various neurological disorders. This category of inhibitors is crucial for advancing our understanding of fundamental neurobiological processes and for exploring the potential impacts of receptor modulation on brain function. View detailed information on our available KA Inhibitors by clicking on the product name.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

UBP 301

569371-10-4sc-203716
sc-203716A
10 mg
50 mg
$388.00
$1533.00
(0)

UBP 301 acts as a selective inhibitor of kinases, showcasing a unique ability to modulate specific signaling pathways. Its structure allows for precise interactions with the ATP-binding site, leading to competitive inhibition. The compound's kinetic profile reveals a rapid association and slower dissociation, enhancing its efficacy. Furthermore, UBP 301's solubility in polar solvents facilitates its integration into diverse biochemical assays, making it a versatile tool for studying kinase activity.